Scholarlink

<p>Chickenpox is a highly contagious viral infection caused by varicella-zoster virus (VZV) whose clinical manifestations mimic mpox posing challenges for diagnosis without laboratory confirmation. Here, we investigated VZV among the mpox-suspected cases, May to October 2022, in Ethiopia. Samples were collected from 202 mpox-suspected cases in 11 of Ethiopia’s 14 regions and screened for mpox virus by real-time polymerase chain reaction (RT-PCR). Then, differential testing of other selected orthopoxviruses, VZV and herpes simplex virus (HSV) were conducted for 133 randomly selected samples. Whole-genome sequencing (WGS) and downstream analysis was performed on 8 VZV-positive samples. Descriptive statistics were used to summarize epidemiological and clinical data. All the 202 enrolled cases tested negative for mpox. Of these, 133 samples were tested for VZV, and 107 (80.5%, 95% CI: 72.9% – 86.3%) turned positive but remained negative for HSV and other tested orthopoxviruses. At least one VZV-positive case was reported in each region sampled. Half (49.6%) of the cases were hospitalized, with no fatalities. The sequences were clustered primarily in Clade 5 (62.5%, 5) followed by Clade 3 (25.0%, 2) and Clade 1 (12.5%, 1). This investigation confirmed VZV as the predominant causative agent among mpox-suspected cases. To our knowledge, this represents the first clade-level genomic characterization of VZV from Ethiopia, revealing circulation of multiple clades among samples collected during May to October 2022. The findings highlight the need to strengthen differential diagnostic capacities including multiplex testing, and building genomic surveillance capacities for epidemic intelligence and outbreak response.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Genomic evidence of varicella-zoster virus among Mpox-suspected cases in Ethiopia during the 2022 Mpox multi-country outbreak

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月23日

查看全文
  • Adamu Tayachew,
  • Nigatu Kebede,
  • Mikias Alayu,
  • Harris Onywera,
  • Stephen Kanyerezi,
  • Adimikew Agune,
  • Wolde Shure,
  • Ayele Gebeyehu,
  • Tsegaye Berkesa,
  • Melak Getu,
  • Lijalem Gedefaw,
  • Hiwot Amare,
  • Biaz Amuri,
  • Placide Mbala,
  • Dorcas W. Wanjohi,
  • Sofonias K. Tessema,
  • Gizaw Teka,
  • Mandefro Kebede,
  • Christopher H. Logue,
  • Mesay Hailu,
  • Dawit Assefa Arimide,
  • Melkamu Abte,
  • Mesfin Wossen

摘要

Chickenpox is a highly contagious viral infection caused by varicella-zoster virus (VZV) whose clinical manifestations mimic mpox posing challenges for diagnosis without laboratory confirmation. Here, we investigated VZV among the mpox-suspected cases, May to October 2022, in Ethiopia. Samples were collected from 202 mpox-suspected cases in 11 of Ethiopia’s 14 regions and screened for mpox virus by real-time polymerase chain reaction (RT-PCR). Then, differential testing of other selected orthopoxviruses, VZV and herpes simplex virus (HSV) were conducted for 133 randomly selected samples. Whole-genome sequencing (WGS) and downstream analysis was performed on 8 VZV-positive samples. Descriptive statistics were used to summarize epidemiological and clinical data. All the 202 enrolled cases tested negative for mpox. Of these, 133 samples were tested for VZV, and 107 (80.5%, 95% CI: 72.9% – 86.3%) turned positive but remained negative for HSV and other tested orthopoxviruses. At least one VZV-positive case was reported in each region sampled. Half (49.6%) of the cases were hospitalized, with no fatalities. The sequences were clustered primarily in Clade 5 (62.5%, 5) followed by Clade 3 (25.0%, 2) and Clade 1 (12.5%, 1). This investigation confirmed VZV as the predominant causative agent among mpox-suspected cases. To our knowledge, this represents the first clade-level genomic characterization of VZV from Ethiopia, revealing circulation of multiple clades among samples collected during May to October 2022. The findings highlight the need to strengthen differential diagnostic capacities including multiplex testing, and building genomic surveillance capacities for epidemic intelligence and outbreak response.